Their findings suggest an intimate relationship between COVID-19 and BRD4 and demonstrate that BET bromodomain inhibition can reduce cardiac stress and improve relaxation of the heart in the face of a cytokine storm triggered by SARS-CoV-2 infection. This evidence concerns the gene BRD4 and COVID-19.